EverydayHealthLogo
CD

Dr. Charles Debattista, MD

Stanford, CA

30 Years of Experience

Accepting patients

Affiliated with a Castle Connolly Top Hospital

    Who is Dr. Debattista, Psychiatrist in Stanford, CA?

    Dr. Charles Debattista, MD is a Psychiatrist, who primarily practices in Stanford, CA with 1 additional practice location. He has been practicing for over 30 years and is board certified by the American Board of Psychiatry and Neurology. Dr. Debattista graduated from University of California and completed his residency at Stanford Univ Hosp, Psychiatry. Dr. Debattista is fluent in English, and is currently seeing new patients. Dr. Debattista’s practice accepts Kaiser Permanente, Medicaid, Medicare, UnitedHealthcare and other major insurance plans. To book an appointment or to confirm insurance options, please call Dr. Debattista’s office at (650) 498-9111.

    Where did Dr. Debattista go to medical school and complete their residency?

    • Fellowship: Stanford University Medical Center CA

    • Residency: Stanford Univ Hosp, Psychiatry | Stanford University Hospital | Stanford University Medical Center | Stanford University Program

    • Medical School: University of Ca, San Francisco, Sch of Med, San Francisco Ca | University of California

    Is Dr. Debattista board certified in Psychiatrist?

    Yes, Dr. Charles Debattista, MD is board certified by the American Board of Psychiatry and Neurology , American Board of Psychiatry and Neurology since 1995

    What languages does Dr. Debattista speak?

    Dr. Debattista and their clinical team can communicate with patients in the following languages:

    • English

    What conditions does Dr. Debattista treat?

    As a Psychiatrist, Dr. Debattista diagnoses, treats, and manages a wide range of conditions. This condition information is derived from anonymized insurance claims and highlights the medical conditions most commonly treated by Dr. Debattista. It provides insight into the doctor’s areas of experience and expertise based on real-world patient encounters from the past two years, updated quarterly.

    Also known as:

    • Recurrent Severe Depression
    • Moderate Recurrent Major Depression
    • Recurrent Depression in Partial Remission
    • Depression
    • Recurrent Major Depression in Full Remission
    • Recurrent Depression
    • Chronic severe depression
    • Repeated severe depressive episodes
    • Clinical depression
    • Moderate chronic depression
    • Moderate recurring depression
    • Moderate depressive episodes
    • Improving recurrent depression
    • Resolving recurrent depressive symptoms
    • Partial recovery from recurrent depression
    • Major depressive disorder
    • Mood disorder
    • Chronic depression in full remission
    • Full recovery from recurring depression
    • Depression well-managed
    • Chronic depression
    • Repeated depressive episodes

    ICD-10 Codes:

    • F332: Major depressive disorder, recurrent severe without psychotic features
    • F331: Major depressive disorder, recurrent, moderate
    • F3341: Major depressive disorder, recurrent, in partial remission
    • F32A: Depression, unspecified
    • F3342: Major depressive disorder, recurrent, in full remission
    • F339: Major depressive disorder, recurrent, unspecified

    Also known as:

    • Bipolar Disorder
    • Manic depression
    • Bipolar illness
    • Mood disorder

    ICD-10 Codes:

    • F319: Bipolar disorder, unspecified

    Does Dr. Debattista accept my insurance?

    Dr. Debattista accepts most major insurance plans. Important: Please call our office at (650) 498-9111 before your appointment to verify that your specific plan and network are accepted.

    What insurance plans does Dr. Debattista accept in Stanford, CA?

    Dr. Debattista in Stanford, CA accepts plans from many carriers. While this list is updated regularly, it is not a guarantee of coverage.

    Top Insurances

    • All Other Third Party

    • Blue Shield of California

    • Crown Cork and Seal Company

    • CVS Health (formerly Aetna)

    • Express Scripts

    • Kaiser Permanente

    • Medicare

    • OptumRx

    • State of Tennessee

    • UnitedHealthcare

    View All Insurances

    Where is Dr. Debattista's office located?

    Dr. Charles Debattista's Primary Practice

    300 Pasteur Dr

    Stanford, CA 94305

    (650) 498-9111

    Get Directions

    Dr. Charles Debattista's Practice 2

    401 Quarry Rd

    Palo Alto, CA 94304

    Get Directions

    Recognitions

    Awards

    America's Best Doctors

    Psychiatry, Best Doctors

    Review Article of the Year, Primary Psychiatry

    Teacher of the Year, Dept. Of Psychiatry

    Publications

    Measuring severe adverse events

    NEUROPSYCHIATRIC DISEASE AND TREATMENT, 2012

    The use of referenced-EEG (rEEG) in assisting medication selection for the treatment of depression

    JOURL OF PSYCHIATRIC RESEARCH, 2011

    Safety considerations of the use of second generation antipsychotics

    Current drug safety, 2010

    Effects of major depression diagnosis and cortisol levels on indices of neurocognitive function

    PSYCHONEUROENDOCRINOLOGY, 2009

    A multisite trial of mifepristone for the treatment of psychotic depression

    CONTEMPORARY CLINICAL TRIALS, 2009

    Utility of Atypical Antipsychotics in the Treatment of Resistant Unipolar Depression

    CNS DRUGS, 2009

    Sildefil treatment of women with antidepressant-associated sexual dysfunction - A r

    JAMA-JOURL OF THE AMERICAN MEDICAL ASSOCIATION, 2008

    Depression and smoking cessation: does the evidence support psychiatric practice?

    Neuropsychiatric disease and treatment, 2007

    Modafinil augmentation of selective serotonin reuptake inhibitor therapy

    Anls of clinical psychiatry, 2007

    Mifepristone versus placebo in the treatment of psychosis in patients with psychotic major

    BIOLOGICAL PSYCHIATRY, 2006

    The neuropsychological profile of psychotic major depression and its relation to cortisol

    BIOLOGICAL PSYCHIATRY, 2006

    The efficacy of mifepristone in the reduction

    BEHAVIOURAL BRAIN RESEARCH, 2006

    Augmentation and combition strategies for depression

    JOURL OF PSYCHOPHARMACOLOGY, 2006

    The use of mifepristone in the treatment of neuropsychiatric disorders

    TRENDS IN ENDOCRINOLOGY AND METABOLISM, 2006

    Modafinil augmentation of SSRI therapy in patients with major depressive disorder

    CNS SPECTRUMS, 2006

    Detecting psychotic major depression using psychiatric rating scales

    JOURL OF PSYCHIATRIC RESEARCH, 2006

    Update on augmentation of antidepressant response in resistant depression.

    Current psychiatry reports, 2005

    The efficacy of divalproex sodium in the treatment of agitation associated with major depression

    JOURL OF CLINICAL PSYCHOPHARMACOLOGY, 2005

    A placebo-controlled, randomized

    JOURL OF CLINICAL PSYCHIATRY, 2005

    C-1073 (mifepristone) in the adjunctive treatment of Alzheimer's disease.

    Current Alzheimer research, 2005

    Executive dysfunction in major depressive disorder.

    Expert review of neurotherapeutics, 2005

    A multicenter, placebo

    JOURL OF CLINICAL PSYCHIATRY, 2005

    HPA axis activation in major depression and response to fluoxetine: a pilot study

    PSYCHONEUROENDOCRINOLOGY, 2004

    A prospective trial of modafinil as an adjunctive treatment of major depression

    JOURL OF CLINICAL PSYCHOPHARMACOLOGY, 2004

    Seizure duration with remifentanil

    ACTA AESTHESIOLOGICA SCANDIVICA, 2003

    Adjunct modafinil for the short-term treatment of fatigue

    JOURL OF CLINICAL PSYCHIATRY, 2003

    Safety of antidepressants in the elderly.

    Expert opinion on drug safety, 2003

    A prospective trial of bupropion SR augmentation of partial

    JOURL OF CLINICAL PSYCHOPHARMACOLOGY, 2003

    The timing of electroconvulsive therapy

    JOURL OF CLINICAL ANESTHESIA, 2003

    Fetal heart rate decelerations during ECT-induced seizures: is it important?

    ACTA AESTHESIOLOGICA SCANDIVICA, 2003

    An open label trial of C-1073 (mifepristone) for psychotic major depression

    BIOLOGICAL PSYCHIATRY, 2002

    Slowing the progression of cognitive decline in Alzheimer's disease using mifepristone

    JOURL OF MOLECULAR NEUROSCIENCE, 2002

    Cortisol feedback during the HPA quiescent period in patients with major depression

    AMERICAN JOURL OF PSYCHIATRY, 2001

    Is electroconvulsive therapy effective for the depressed patient

    JOURL OF ECT, 2001

    Sertraline versus imipramine to prevent relapse in chronic depression

    JOURL OF AFFECTIVE DISORDERS, 2001

    Psychopharmacologic treatment strategies for depression, bipolar disorder, and schizophrenia

    ANLS OF INTERL MEDICINE, 2001

    Acute antidepressant effects of intravenous hydrocortisone and CRH in depressed patients

    AMERICAN JOURL OF PSYCHIATRY, 2000

    24-hour monitoring of cortisol and corticotropin secretion in psychotic and nonpsychotic major

    Posener, J. A., Debattista, C., Williams, G. H., Kraemer, H. C., Kaleh, 2000

    Neuropsychological deficits in psychotic versus nonpsychotic major depression and no mental illness

    AMERICAN JOURL OF PSYCHIATRY, 2000

    Pramipexole augmentation of a selective serotonin reuptake inhibitor in the treatment of depression

    JOURL OF CLINICAL PSYCHOPHARMACOLOGY, 2000

    Negative-pressure pulmory edema: A potential mazard in patients undergoing ECT

    JOURL OF ECT, 1999

    The Texas Medication Algorithm Project

    JOURL OF CLINICAL PSYCHIATRY, 1999

    Phenomenology and treatment of agitation

    Schatzberg, A. F., Debattista, C., 1999

    ECT in dissociative identity disorder and comorbid depression

    JOURL OF ECT, 1998

    Serotonergic synergism

    BIOLOGICAL PSYCHIATRY, 1998

    Developing treatment algorithms for unipolar depression in cyberspace

    PSYCHOPHARMACOLOGY BULLETIN, 1998

    Treatment of psychotic depression

    AMERICAN JOURL OF PSYCHIATRY, 1997

    Development of obsessive symptoms during nefazodone treatment

    AMERICAN JOURL OF PSYCHIATRY, 1996

    SUMATRIPTAN PROPHYLAXIS FOR POSTELECTROCONVULSIVE THERAPY HEADACHES

    HEADACHE, 1995

    PHYSICAL SYMPTOMS ASSOCIATED WITH PAROXETINE WITHDRAWAL

    AMERICAN JOURL OF PSYCHIATRY, 1995

    What is Dr. Debattista's NPI number?An National Provider Identifier (NPI) is a unique ID number that identifies doctors and healthcare providers nationwide.

    Dr. Debattista's National Provider Identifier (NPI) number is 1982749941.

    What common questions do patients ask about Dr. Debattista?

    Here are answers to patients Frequently Asked Questions (FAQ’s) about Dr. Debattista

    What is Dr. Charles Debattista's specialty?

    Dr. Debattista is a Psychiatrist near Stanford, CA.

    A Psychiatrist specializes in the prevention, diagnosis, and treatment of mental disorders, emotional disorders, psychotic disorders, mood disorders, anxiety disorders, substance-related disorders, sexual and gender identity disorders and adjustment disorders. Biologic, psychological, and social components of illnesses are explored and understood in treatment of the whole person. Tools used may include diagnostic laboratory tests, prescribed medications, evaluation and treatment of psychological and interpersonal problems with individuals and families, and intervention for coping with stress, crises, and other problems.

    Contact Dr. Debattista to book an appointment today.

    Is this Dr. Charles Debattista affiliated with a ranked Castle Connolly Top Hospital?

    Yes, Dr. Debattista is affiliated with Stanford Health Care - Stanford Hospital which is a Castle Connolly Top Hospital. Castle Connolly Top Hospitals are healthcare institutions recognized for their excellence in specific medical procedures and overall patient care. They are identified through a rigorous peer nomination process, evaluating factors like patient outcomes, quality of care, and expertise. The list recognizes hospitals that excel in 20 or more specific medical procedures, representing the top 25% nationwide. Castle Connolly Top Hospitals

    Where can I learn more about Psychiatrist?

    Explore Psychiatrist with insights from trusted medical experts on EverydayHealth.com, where you'll find the most relevant content and helpful condition guides for up-to date information about symptoms, causes, diagnosis, treatment and more. See all our health guides to find trusted information on medical conditions from our experts at Everyday Health.

    Is Charles Debattista accepting new patients in Stanford, CA?

    Yes, Dr. Charles Debattista is accepting new patients at this time.

    Does Dr. Charles Debattista offer online booking?

    Please contact Dr. Debattista's office at (650) 498-9111 for information about online booking, telehealth, or to schedule an appointment.

    How can I make an appointment with Charles Debattista?

    Please contact Dr. Debattista's office at (650) 498-9111 for information regarding telehealth appointment availability or for scheduling assistance.

    Which board certifications does Dr. Charles Debattista have?

    Dr. Charles Debattista is certified by the American Board of Psychiatry and Neurology.

    Other Psychiatrist Near Stanford, CA

    JE
    acceptingPatients-iconAccepting patients
    Stanford, CA
    MP

    Addiction Medicine Specialist

    acceptingPatients-iconAccepting patients
    Stanford, CA
    acceptingPatients-iconAccepting patients
    Stanford, CA
    See All Specialists

    Doctors by Category

    Specialists